Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-11 Sale | 2025-08-11 4:35 pm | Royalty Pharma plc | RPRX | Norden Gregory Director | 33,500 | $36.23 | $1,213,749 | 194,848 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-08 Conversion | 2025-08-11 4:35 pm | N/A N/A | Royalty Pharma plc | RPRX | Norden Gregory Director | 159,126 | $0 | 194,848 (Direct) | View |
| 2025-08-08 Gift | 2025-08-08 5:00 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 60,000 | $0 | 10,888,337 (Direct) | View |
| 2025-08-06 Option Award | 2025-08-08 5:00 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 21,901 | $0 | 10,888,337 (Direct) | View |
| 2025-08-08 Gift | 2025-08-08 4:58 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 1,000 | $0 | 1,537,550 (Indirect) | View |
| 2025-08-06 Option Award | 2025-08-08 4:58 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 3,696 | $0 | 1,537,550 (Indirect) | View |
| 2025-08-08 Gift | 2025-08-08 4:56 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 8,500 | $0 | 1,881,905 (Direct) | View |
| 2025-08-06 Option Award | 2025-08-08 4:56 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 3,696 | $0 | 1,881,905 (Indirect) | View |
| 2025-08-06 Option Award | 2025-08-08 4:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman | 3,696 | $0 | 722,342 (Indirect) | View |
| 2025-08-08 Gift | 2025-08-08 4:52 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 3,000 | $0 | 368,355 (Indirect) | View |
| 2025-08-06 Option Award | 2025-08-08 4:52 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 2,772 | $0 | 368,355 (Direct) | View |
| 2025-07-31 Option Award | 2025-07-31 8:45 pm | N/A N/A | Royalty Pharma plc | RPRX | WEATHERMAN ELIZABETH H Director | 8,558 | $0 | 8,558 (Direct) | View |
| 2025-07-31 Option Award | 2025-07-31 8:42 pm | N/A N/A | Royalty Pharma plc | RPRX | Ho Carole Director | 8,558 | $0 | 8,558 (Direct) | View |
| 2025-06-30 Option Award | 2025-06-30 5:06 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 1,064 | $35.24 | 123,524 (Direct) | View |
| 2025-06-30 Option Award | 2025-06-30 5:04 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 1,064 | $35.24 | 71,118 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-20 4:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman | 1,238,789 | $0 | 1,238,789 (Indirect) | View |
| 2025-05-16 Option Award | 2025-05-20 4:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 1,356,528 | $0 | 1,356,528 (Indirect) | View |
| 2025-05-16 Option Award | 2025-05-20 4:52 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 1,807,277 | $0 | 1,807,277 (Indirect) | View |
| 2025-05-16 Option Award | 2025-05-20 4:51 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 1,944,471 | $0 | 1,944,471 (Indirect) | View |
| 2025-05-16 Other | 2025-05-20 4:49 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 1,387,486 | $0 | 19,231,098 (Indirect) | View |
| 2025-05-16 Option Award | 2025-05-20 4:49 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 13,356,742 | $0 | 19,231,098 (Indirect) | View |
| 2025-05-13 Option Award | 2025-05-15 5:41 pm | N/A N/A | Royalty Pharma plc | RPRX | Engelbert Catherine M. Director | 7,614 | $0 | 51,128 (Direct) | View |
| 2025-05-13 Option Award | 2025-05-14 5:12 pm | N/A N/A | Royalty Pharma plc | RPRX | Norden Gregory Director | 7,614 | $0 | 83,688 (Direct) | View |
| 2025-05-13 Option Award | 2025-05-14 5:11 pm | N/A N/A | Royalty Pharma plc | RPRX | LOVE TED W Director | 7,614 | $0 | 53,848 (Direct) | View |
| 2025-05-13 Option Award | 2025-05-14 5:09 pm | N/A N/A | Royalty Pharma plc | RPRX | HODGSON DAVID C Director | 7,614 | $0 | 33,328 (Direct) | View |
| 2025-05-13 Option Award | 2025-05-14 5:08 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 7,614 | $0 | 122,460 (Direct) | View |
| 2025-05-13 Option Award | 2025-05-14 5:07 pm | N/A N/A | Royalty Pharma plc | RPRX | DESOUZA ERROL B Director | 7,614 | $0 | 81,352 (Direct) | View |
| 2025-05-13 Option Award | 2025-05-14 5:06 pm | N/A N/A | Royalty Pharma plc | RPRX | Coric Vlad Director | 7,614 | $0 | 10,798 (Direct) | View |
| 2025-05-13 Option Award | 2025-05-14 5:04 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 7,614 | $0 | 70,054 (Direct) | View |
| 2025-05-12 Gift | 2025-05-14 5:02 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 1,734,360 | $0 | 9,700,000 (Indirect) | View |
| 2025-05-08 Option Award | 2025-05-09 5:18 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 288,352 | $0 | 3,956,522 (Direct) | View |
| 2025-05-08 Option Award | 2025-05-09 5:15 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 48,646 | $0 | 1,125,477 (Indirect) | View |
| 2025-05-08 Option Award | 2025-05-09 5:14 pm | N/A N/A | Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman | 48,646 | $0 | 718,646 (Indirect) | View |
| 2025-05-08 Option Award | 2025-05-09 5:10 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 48,646 | $0 | 889,036 (Indirect) | View |
| 2025-05-08 Option Award | 2025-05-09 5:07 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 36,484 | $0 | 102,171 (Direct) | View |
| 2025-04-21 Option Award | 2025-04-21 5:43 pm | N/A N/A | Royalty Pharma plc | RPRX | Coric Vlad Director | 3,184 | $0 | 3,184 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-01 5:46 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 1,141 | $32.87 | 62,440 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-01 5:45 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 1,141 | $32.87 | 114,846 (Direct) | View |
| 2025-02-14 Conversion | 2025-02-18 5:16 pm | N/A N/A | Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman | 330,000 | $0 | 756,641 (Indirect) | View |
| 2024-12-31 Option Award | 2025-01-02 4:29 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 1,503 | $24.94 | 61,299 (Direct) | View |
| 2024-12-31 Option Award | 2025-01-02 4:28 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 1,503 | $24.94 | 113,705 (Direct) | View |
| 2024-09-30 Option Award | 2024-09-30 5:08 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 1,342 | $27.92 | 59,796 (Direct) | View |